Bisubstrate Adenylation Inhibitors of Biotin Protein Ligase from Mycobacterium Tuberculosis

Total Page:16

File Type:pdf, Size:1020Kb

Bisubstrate Adenylation Inhibitors of Biotin Protein Ligase from Mycobacterium Tuberculosis View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Chemistry & Biology Article Bisubstrate Adenylation Inhibitors of Biotin Protein Ligase from Mycobacterium tuberculosis Benjamin P. Duckworth,1 Todd W. Geders,2 Divya Tiwari,3 Helena I. Boshoff,4 Paul A. Sibbald,1 Clifton E. Barry, III,4 Dirk Schnappinger,3 Barry C. Finzel,2 and Courtney C. Aldrich1,* 1Center for Drug Design, University of Minnesota, Minneapolis, MN 55455, USA 2Department of Medicinal Chemistry, University of Minnesota, Minneapolis, MN 55455, USA 3Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA 4Tuberculosis Research Section, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA *Correspondence: [email protected] DOI 10.1016/j.chembiol.2011.08.013 SUMMARY the type II fatty acid synthase (FAS-II) in Mtb (Slayden et al., 2000; Timm et al., 2003). Acyl coenzyme A carboxylases The mycobacterial biotin protein ligase (MtBPL) (ACCs) catalyze the first committed step in fatty acid biosyn- globally regulates lipid metabolism in Mtb through thesis through synthesis of the monomeric malonyl-CoA building the posttranslational biotinylation of acyl coenzyme blocks. However, unlike most bacteria that encode for a single A carboxylases involved in lipid biosynthesis that ACC complex, Mtb encodes for multiple ACCs responsible for catalyze the first step in fatty acid biosynthesis and the biosynthesis of malonyl coenzyme A (CoA), (methyl)malonyl pyruvate coenzyme A carboxylase, a gluconeogenic CoA, and (C22–C24) malonyl CoA for construction of the struc- turally diverse lipids in Mtb, including simple linear fatty acids, enzyme vital for lipid catabolism. Here we describe methyl-branched lipids, and mycolic acids (Gago et al., 2006; the design, development, and evaluation of a ratio- Kurth et al., 2009; Portevin et al., 2005). In order for the ACCs nally designed bisubstrate inhibitor of MtBPL. This to become functionally active, the biotin-carboxylase carrier inhibitor displays potent subnanomolar enzyme protein (BCCP) domains of these proteins must be posttransla- inhibition and antitubercular activity against multi- tionally modified to their active holo biotinylated form by a biotin drug resistant and extensively drug resistant Mtb protein ligase (BPL) encoded by birA in Mtb (MtBPL) (Purusho- strains. We show that the inhibitor decreases in vivo thaman et al., 2008). The biotin serves as the cofactor that medi- protein biotinylation of key enzymes involved in ates carboxyl group transfer onto the acetyl CoA substrates. In fatty acid biosynthesis and that the antibacterial addition to fatty acid biosynthesis, fatty acid degradation is activity is MtBPL dependent. Additionally, the gene also an essential process, and mycobacteria are thought to be encoding BPL was found to be essential in primarily lipolytic in vivo deriving their energy via fatty acid catab- olism (Timm et al., 2003). MtBPL may also play a key role in fatty M. smegmatis. Finally, the X-ray cocrystal structure acid degradation, because this enzyme is also responsible for of inhibitor bound MtBPL was solved providing biotinylation of the BCCP domain of pyruvate carboxylase, detailed insight for further structure-activity analysis. which can channel oxaloacetate to the phosphoenolpyruvate Collectively, these data suggest that MtBPL is carboxykinase, a gluconeogenic enzyme that is essential for a promising target for further antitubercular thera- growth on fatty acids and critical for mycobacterial pathogenesis peutic development. (Marrero et al., 2010). MtBPL thus globally regulates lipid metab- olism and represents an attractive target for development of new antitubercular agents. INTRODUCTION There are two classes of biotin protein ligases (BPLs): the monofunctional enzymes represented by the BPL from Tuberculosis (TB) caused by the bacterium Mycobacterium Pyrococcus horikoshii (PhBPL), which solely catalyze posttrans- tuberculosis (Mtb) continues to burden human health on a global lational biotinylation, and the bifunctional enzymes represented scale. Despite an impressive amount of effort directed at eradi- by the prototypical BPL from Escherichia coli (EcBPL), which cating tuberculosis, TB is still the second leading cause of also act as transcriptional repressors (Brown et al., 2004; mortality among infectious diseases superseded only by HIV. Chapman-Smith and Cronan, 1999). Recent biochemical char- The emergence of multidrug-resistant (MDR) and extensively acterization of the BPL from Mtb (MtBPL) has revealed it to be drug-resistant (XDR) TB strains coupled with the high incidence a monofunctional enzyme that exists as a monomer in both the of HIV-TB coinfection and the lack of any new approved chemo- unliganded apo-and holo-forms as well as in the biotinyl adeny- therapeutic agents for TB in over four decades, demands the late (Bio-AMP, 2) liganded form (Purushothaman et al., 2008). development of new antitubercular agents, ideally with novel BPLs catalyze the transfer of biotin onto a conserved lysine mechanisms of action, to combat this devastating pathogen. residue of the biotin-carboxylase carrier protein (BCCP) domain Fatty acid biosynthesis is a validated pathway for antituber- of ACCs. This reaction is accomplished in two steps: in the first- cular drug discovery, and the first-line agent isoniazid inhibits half reaction, BPLs bind biotin (1, Figure 1A) and ATP and 1432 Chemistry & Biology 18, 1432–1441, November 23, 2011 ª2011 Elsevier Ltd All rights reserved Chemistry & Biology Inhibition of M. tuberculosis Biotin Protein Ligase O NH2 O HN NH N PPi O O O N HN NH O P A O O N N ATP S O OH S BPL 1 2 HO OH O O NH 2 HN NH O HN NH N AMP O N B O O NH2 P NH N S O O N BCCP S O BPL BCCP 3 2 HO OH 4 O NH2 NH2 O N HN NH N N O O O N HN NH O C S O O N N N X N N S S H O N O O S H HO OH HO OH 5, X = O 7 8 6, X = NH Figure 1. Enzyme Reaction Catalyzed by BPL (A) First half-reaction to form biotin adenylate. (B) Second half-reaction involving transfer of biotin to acetyl CoA carboxylases. (C) Bisubstrate inhibitors of BPL and degradation products of 5. See also Figure S1. catalyze the nucleophilic attack of the biotin carboxylate onto the RESULTS a-phosphate of ATP to yield the acyl-adenylate Bio-AMP 2 (Figure 1A) and pyrophosphate. In the second-half reaction, Inhibitor Design and Synthesis BPLs transfer biotin from Bio-AMP 2 onto a conserved lysine Bisubstrate inhibitors that mimic acyl-adenylate reaction inter- residue within the BCCP domain 3 to provide biotinylated- mediates typically bind much more tightly than the individual BCCP 4 (Figure 1B). The bisubstrate inhibitor 5 (Figure 1C) has substrates owing to the large number of interactions between been described, which mimics the intermediate acyl-adenylate the inhibitor and both substrate binding sites (Ferreras et al., Bio-AMP 2 by replacement of the labile acylphosphate linkage 2005; Somu et al., 2006). The reported lack of potency of 5 in Bio-AMP 2 with the bioisosteric acylsulfamate moiety toward EcBPL is surprising (Brown and Beckett, 2005), so we (Brown and Beckett, 2005; Brown et al., 2004). Interestingly, synthesized this compound as described in Supplemental the bisubstrate inhibitor 5 was found to bind 1.4-fold more Experimental Procedures. We immediately observed that it is weakly to EcPBL than the single substrate biotin, suggesting chemically unstable and decomposes through cyclonucleoside the acylsulfamate was a poor isostere for the native acylphos- formation to afford N-biotinylsulfamic acid 7 (Figure 1C) and phate linkage. 3,50-cyclo-50-deoxyadenosine 8 (experimental details and com- Here we describe the design, synthesis, biochemical, struc- plete characterization are found in the Supplemental Informa- tural, and biological evaluation of a bisubstrate inhibitor of tion). We hypothesized that a more stable compound would MtBPL that we term Bio-AMS (6, Figure 1C) which binds more result if the 50-oxygen atom in sulfamate 5 were replaced with than 1700-fold more tightly than biotin and possesses potent a nitrogen atom of sulfamide 6 as a result of the decreased nucle- and selective antimicrobial activity against MDR- and XDR-TB ofugality of the sulfamide (Broeckaert et al., 2008). Compound 6 strains of Mtb. We used M. smegmatis to confirm that the (Bio-AMS) was synthesized, and as predicted, it did not undergo BPL-encoding gene, birA, is essential as well as to assess cyclonucleoside formation. Because of its improved stability, susceptibility of MtBPL to inhibition in vivo. Support for the de- Bio-AMS represents an excellent probe to chemically validate signed mechanism of action is provided using a combination MtBPL as a target for antitubercular therapeutic development. of proteomic profiling and genetic studies. Finally, we describe the detailed molecular interactions present between MtBPL Biochemical Evaluation of Bio-AMS and Bio-AMS that establish the molecular basis for potent inhibi- We next evaluated Bio-AMS in a kinetic continuous coupled tion and provides a framework for future structure-aided drug assay with 250 nM MtBPL to determine the concentration- design. response curve for inhibition of MtBPL at fixed saturating Chemistry & Biology 18, 1432–1441, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1433 Chemistry & Biology Inhibition of M. tuberculosis Biotin Protein Ligase Time, min A 1.0 B 0 20 40 60 80 100 120 9.6 0.8 ce 9.4 s /l 0.6 acµ 9.2 0 9.0 /v i v 0.4 t 8.8 n a t 0 0.2 cej nifol -2 -4 0.0 o m/l -6 0 250 500 750 1000 ac k Bio-AMS, nM 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2 180 Molar Ratio of Bio-AMS:MtBPL C D 116 97 100 57 75 d% ensity ze 40 t 50 normali 29 in band 25 20 0 0 0.1 1.0 14 Bio-AMS, µM M 1 2 3 Figure 2.
Recommended publications
  • Anti-Inflammatory Role of Curcumin in LPS Treated A549 Cells at Global Proteome Level and on Mycobacterial Infection
    Anti-inflammatory Role of Curcumin in LPS Treated A549 cells at Global Proteome level and on Mycobacterial infection. Suchita Singh1,+, Rakesh Arya2,3,+, Rhishikesh R Bargaje1, Mrinal Kumar Das2,4, Subia Akram2, Hossain Md. Faruquee2,5, Rajendra Kumar Behera3, Ranjan Kumar Nanda2,*, Anurag Agrawal1 1Center of Excellence for Translational Research in Asthma and Lung Disease, CSIR- Institute of Genomics and Integrative Biology, New Delhi, 110025, India. 2Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India. 3School of Life Sciences, Sambalpur University, Jyoti Vihar, Sambalpur, Orissa, 768019, India. 4Department of Respiratory Sciences, #211, Maurice Shock Building, University of Leicester, LE1 9HN 5Department of Biotechnology and Genetic Engineering, Islamic University, Kushtia- 7003, Bangladesh. +Contributed equally for this work. S-1 70 G1 S 60 G2/M 50 40 30 % of cells 20 10 0 CURI LPSI LPSCUR Figure S1: Effect of curcumin and/or LPS treatment on A549 cell viability A549 cells were treated with curcumin (10 µM) and/or LPS or 1 µg/ml for the indicated times and after fixation were stained with propidium iodide and Annexin V-FITC. The DNA contents were determined by flow cytometry to calculate percentage of cells present in each phase of the cell cycle (G1, S and G2/M) using Flowing analysis software. S-2 Figure S2: Total proteins identified in all the three experiments and their distribution betwee curcumin and/or LPS treated conditions. The proteins showing differential expressions (log2 fold change≥2) in these experiments were presented in the venn diagram and certain number of proteins are common in all three experiments.
    [Show full text]
  • Supplemental Methods
    Supplemental Methods: Sample Collection Duplicate surface samples were collected from the Amazon River plume aboard the R/V Knorr in June 2010 (4 52.71’N, 51 21.59’W) during a period of high river discharge. The collection site (Station 10, 4° 52.71’N, 51° 21.59’W; S = 21.0; T = 29.6°C), located ~ 500 Km to the north of the Amazon River mouth, was characterized by the presence of coastal diatoms in the top 8 m of the water column. Sampling was conducted between 0700 and 0900 local time by gently impeller pumping (modified Rule 1800 submersible sump pump) surface water through 10 m of tygon tubing (3 cm) to the ship's deck where it then flowed through a 156 µm mesh into 20 L carboys. In the lab, cells were partitioned into two size fractions by sequential filtration (using a Masterflex peristaltic pump) of the pre-filtered seawater through a 2.0 µm pore-size, 142 mm diameter polycarbonate (PCTE) membrane filter (Sterlitech Corporation, Kent, CWA) and a 0.22 µm pore-size, 142 mm diameter Supor membrane filter (Pall, Port Washington, NY). Metagenomic and non-selective metatranscriptomic analyses were conducted on both pore-size filters; poly(A)-selected (eukaryote-dominated) metatranscriptomic analyses were conducted only on the larger pore-size filter (2.0 µm pore-size). All filters were immediately submerged in RNAlater (Applied Biosystems, Austin, TX) in sterile 50 mL conical tubes, incubated at room temperature overnight and then stored at -80oC until extraction. Filtration and stabilization of each sample was completed within 30 min of water collection.
    [Show full text]
  • Stabilization of Fatty Acid Synthesis Enzyme Acetyl-Coa Carboxylase 1 Suppresses Acute Myeloid Leukemia Development
    Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development Hidenori Ito, … , Jun-ya Kato, Noriko Yoneda-Kato J Clin Invest. 2021;131(12):e141529. https://doi.org/10.1172/JCI141529. Research Article Oncology Graphical abstract Find the latest version: https://jci.me/141529/pdf The Journal of Clinical Investigation RESEARCH ARTICLE Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development Hidenori Ito, Ikuko Nakamae, Jun-ya Kato, and Noriko Yoneda-Kato Laboratory of Tumor Cell Biology, Division of Biological Science, Graduate School of Science and Technology, Nara Institute of Science and Technology, Nara, Japan. Cancer cells reprogram lipid metabolism during their malignant progression, but limited information is currently available on the involvement of alterations in fatty acid synthesis in cancer development. We herein demonstrate that acetyl- CoA carboxylase 1 (ACC1), a rate-limiting enzyme for fatty acid synthesis, plays a critical role in regulating the growth and differentiation of leukemia-initiating cells. The Trib1-COP1 complex is an E3 ubiquitin ligase that targets C/EBPA, a transcription factor regulating myeloid differentiation, for degradation, and its overexpression specifically induces acute myeloid leukemia (AML). We identified ACC1 as a target of the Trib1-COP1 complex and found that an ACC1 mutant resistant to degradation because of the lack of a Trib1-binding site attenuated complex-driven leukemogenesis. Stable ACC1 protein expression suppressed the growth-promoting activity and increased ROS levels with the consumption of NADPH in a primary bone marrow culture, and delayed the onset of AML with increases in mature myeloid cells in mouse models.
    [Show full text]
  • A Diverse Superfamily of Enzymes with ATP-Dependent Carboxylate-Amine/Thiol Ligase Activity
    Prorein Science (1997). 6:2639-2643. Cambridge University Press. Printed in the USA. Copyright 0 1997 The Protein Society FOR THE RECORD A diverse superfamily of enzymes with ATP-dependent carboxylate-amine/thiol ligase activity MICHAEL Y. GALPERIN AND EUGENE V. KOONIN National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894 (RECEIVEDJune 12, 1997; ACCEFTEDSeptember 8, 1997) Abstract: The recently developed PSI-BLAST method for se- et al., 1997). All these enzymes catalyze a reaction that involves an quence database search and methods for motif analysis were used ATP-dependent ligation of a carboxyl group carbon of one sub- to define and expand a superfamily of enzymes with an unusual strate with an amino or imino group nitrogen of the second one and nucleotide-binding fold, referred to as palmate, or ATP-grasp fold. includes, in each case, the formation of acylphosphate intermedi- In addition to D-alanine-D-alanine ligase, glutathione synthetase, ates (Gushima et al., 1983; Ogita& Knowles, 1988; Meister, 1989; biotin carboxylase, and carbamoyl phosphate synthetase, enzymes Fan et al., 1994). Structural alignment of DD-ligase, GSHase, and with known three-dimensional structures, the ATP-grasp domain is BCase revealed threeconserved motifs, corresponding to the predicted in the ribosomal protein S6 modification enzyme (RimK), phosphate-binding loop and the Mg2+-binding site of the ATP- urea amidolyase, tubulin-tyrosine ligase, and three enzymes of binding domain (Artymiuk et al., 1996). In each of these enzymes, purine biosynthesis. All these enzymes possess ATP-dependent ATP binds in a cleft formed by two structural elements, each carboxylate-amine ligase activity, and their catalytic mechanisms containing two antiparallel P-strands and a loop (Hibi etal., 1996).
    [Show full text]
  • Characterisation of Human Holocarboxylase Synthetase
    CHARACTERISATION OF HUMAN HOLOCARBOXYLASE SYNTHETASE by LISA MARIE BAILEY, B.Biotech(Hons) A thesis submitted to the University of Adelaide, South Australia in fulfilment of the requirements for the degree of Doctor of Philosophy School of Molecular and Biomedical Science The University of Adelaide Adelaide, South Australia, 5005 December 2008 Abstract Biotin (also known as vitamin H or vitamin B7) is an essential micronutrient that is utilised by all living organisms. A key enzyme in the lifecycle of biotin is biotin protein ligase (BPL). BPL catalyses the attachment of biotin onto the biotin-requiring enzymes, a family of enzymes that play important roles in essential pathways such as fatty acid synthesis, gluconeogenesis and amino acid metabolism. Whilst there is a catalytic core conserved among the BPLs of all species, the N-terminal region of the molecule varies considerably in length and function. Mammalian BPL, commonly referred to as holocarboxylase synthetase, contains a large N-terminal extension not present in prokaryotes. The function and significance of this N-terminal extension is not understood. The aim of this project was to examine the function of the N-terminal portion of human holocarboxylase synthetase (referred to as HCS). To date, no crystal structure for HCS has been reported. Insights into the enzyme have come from mutagenesis and proteolytic mapping of eukaryotic BPLs. For example, yeast BPL has a large N-terminal extension analogous to HCS. Previous work in our laboratory has investigated yeast BPL by mapping the domain structure using limited proteolysis. It has been shown that the N-terminus plays a critical role in catalysis as its removal renders the enzyme inactive (Polyak et al., 1999).
    [Show full text]
  • Docking of Acetyl-Coa Carboxylase to the Plastid Envelope Membrane Attenuates Fatty Acid Production in Plants
    ARTICLE https://doi.org/10.1038/s41467-020-20014-5 OPEN Docking of acetyl-CoA carboxylase to the plastid envelope membrane attenuates fatty acid production in plants Yajin Ye1, Krisztina Nikovics2, Alexandra To 2, Loïc Lepiniec 2, Eric T. Fedosejevs1, Steven R. Van Doren 1, ✉ Sébastien Baud 2 & Jay J. Thelen 1 1234567890():,; In plants, light-dependent activation of de novo fatty acid synthesis (FAS) is partially mediated by acetyl-CoA carboxylase (ACCase), the first committed step for this pathway. However, it is not fully understood how plants control light-dependent FAS regulation to meet the cellular demand for acyl chains. We report here the identification of a gene family encoding for three small plastidial proteins of the envelope membrane that interact with the α-carboxyltransferase (α-CT) subunit of ACCase and participate in an original mechanism restraining FAS in the light. Light enhances the interaction between carboxyltransferase interactors (CTIs) and α-CT, which in turn attenuates carbon flux into FAS. Knockouts for CTI exhibit higher rates of FAS and marked increase in absolute triacylglycerol levels in leaves, more than 4-fold higher than in wild-type plants. Furthermore, WRINKLED1, a master tran- scriptional regulator of FAS, positively regulates CTI1 expression by direct binding to its promoter. This study reveals that in addition to light-dependent activation, “envelope dock- ing” of ACCase permits fine-tuning of fatty acid supply during the plant life cycle. 1 Department of Biochemistry, Christopher S. Bond Life Sciences Center, University of Missouri-Columbia, 1201 E Rollins, Columbia, MO 65211, USA. 2 Institut ✉ Jean-Pierre Bourgin, INRAE, CNRS, AgroParisTech, Université Paris-Saclay, 78000 Versailles, France.
    [Show full text]
  • Three-Dimensional Structure of the Biotin Carboxylase Subunit of Acetyl-Coa Carboxylaset91 Grover L
    Biochemistry 1994, 33, 10249-10256 10249 Three-Dimensional Structure of the Biotin Carboxylase Subunit of Acetyl-coA Carboxylaset91 Grover L. Waldrop,’ Ivan Rayment, and Hazel M. Holden’ Institute for Enzyme Research, Graduate School and Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53705 Received April 28, 1994; Revised Manuscript Received June 8, 1994” ABSTRACT: Acetyl-coA carboxylase is found in all animals, plants, and bacteria and catalyzes the first committed step in fatty acid synthesis. It is a multicomponent enzyme containing a biotin carboxylase activity, a biotin carboxyl carrier protein, and a carboxyltransferase functionality. Here we report the X-ray structure of the biotin carboxylase component from Escherichia coli determined to 2.4-A resolution. The structure was solved by a combination of multiple isomorphous replacement and electron density modification procedures. The overall fold of the molecule may be described in terms of three structural domains. The N-terminal region, formed by Met l-Ile 103, adopts a dinucleotide binding motif with five strands of parallel @-sheetflanked on either side by a-helices. The “B-domain” extends from the main body of the subunit where it folds into two a-helical regions and three strands of @-sheet. Following the excursion into the B-domain, the polypeptide chain folds back into the body of the protein where it forms an eight- stranded antiparallel @-sheet. In addition to this major secondary structural element, the C-terminal domain also contains a smaller three-stranded antiparallel 0-sheet and seven a-helices. The active site of the enzyme has been identified tentatively by a difference Fourier map calculated between X-ray data from the native crystals and from crystals soaked in a Ag+/biotin complex.
    [Show full text]
  • The Carboxyl Transferase Component of Acetyl Coa Carboxylase: Structural Evidence for Intersubunit Translocation of the Biotin Prosthetic Group
    Proceedings of the National Academy of Sciences Vol. 68, No. 3, pp. 653-657, March 1971 The Carboxyl Transferase Component of Acetyl CoA Carboxylase: Structural Evidence for Intersubunit Translocation of the Biotin Prosthetic Group RAS B. GUCHHAIT, JOEL MOSS, WALTER SOKOLSKI, AND M. DANIEL LANE Department of Physiological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 Communicated by Albert L. Lehninger, January 11, 1971 ABSTRACT An essential protein component of acetyl berts, et al. (3), which is free of biotin and appears to function CoA carboxylase, isolated and extensively purified from in the second half-reaction. The precise role of Eb, whether cell-free extracts of Escherichia coli, has been identified as malonyl CoA:d-biotin carboxyl transferase. This enzyme, catalytic, structural, or otherwise, has remained obscure. which does not contain covalently-bound biotin, catalyzes The present investigation reveals that a protein isolated carboxyl transfer from malonyl CoA to free d-biotin, a from E. coli, having characteristics similar to those reported model reaction for the second step in the carboxylation of for Eb, catalyzes BC- and CCP-independent carboxyl transfer acetyl CoA. The transcarboxylation product, after stabil- ization by methylation, was identified as 1'-N-carboxy-d- from malonyl CoA to free d-biotin to form free carboxybiotin. biotin dimethyl ester. These results indicate the presence This malonyl CoA: d-biotin carboxyl transferase, which has of a biotin site on the carboxyl transferase, distinct from been extensively purified, is devoid of biotin and is required that on the biotin carboxylase, which carries out the first in combination with BC and CCP for acetyl CoA carboxyla- step in the overall process.
    [Show full text]
  • Structure of Carbamoyl Phosphate Synthetase: a Journey of 96 Å from Substrate to Product†,‡ James B
    Biochemistry 1997, 36, 6305-6316 6305 Structure of Carbamoyl Phosphate Synthetase: A Journey of 96 Å from Substrate to Product†,‡ James B. Thoden,§ Hazel M. Holden,*,§ Gary Wesenberg,§ Frank M. Raushel,| and Ivan Rayment*,§ Institute for Enzyme Research, Graduate School, and Department of Biochemistry, College of Agriculture, UniVersity of Wisconsin, Madison, Wisconsin 53705, and Department of Chemistry, Texas A&M UniVersity, College Station, Texas 77843 ReceiVed March 4, 1997; ReVised Manuscript ReceiVed March 25, 1997X ABSTRACT: Carbamoyl phosphate synthetase catalyzes the production of carbamoyl phosphate from bicarbonate, glutamine, and two molecules of MgATP. As isolated from Escherichia coli, the enzyme has a total molecular weight of 160K and consists of two polypeptide chains referred to as the large and small subunits. Here we describe∼ the X-ray crystal structure of this enzyme determined to 2.8 Å resolution in the presence of ADP, Mn2+, phosphate, and ornithine. The small subunit is distinctly bilobal with the active site residues located in the interface formed by the NH2- and COOH-terminal domains. Interestingly, the structure of the COOH-terminal half is similar to that observed in the trpG-type amidotransferase family. The large subunit can be envisioned as two halves referred to as the carboxyphosphate and carbamoyl phosphate synthetic components. Each component contains four distinct domains. Strikingly, the two halves of the large subunit are related by a nearly exact 2-fold rotational axis, thus suggesting that this polypeptide chain evolved from a homodimeric precursor. The molecular motifs of the first three domains observed in each synthetic component are similar to those observed in biotin carboxylase.
    [Show full text]
  • Studies on the Inhibition of Biotin-Containing Carboxylases by Acetyl-Coa Carboxylase Inhibitors
    Studies on the Inhibition of Biotin-Containing Carboxylases by Acetyl-CoA Carboxylase Inhibitors Anja Motel, Simone Günther, Martin Clauss, Klaus Kobek, Manfred Focke, and Hartmut K. Lichtenthaler Botanisches Institut (Pflanzenphysiologie und Pflanzenbiochemie), Universität Karlsruhe, Kaiserstraße 12, D-W-7500 Karlsruhe, Bundesrepublik Deutschland Z. Naturforsch. 48c, 294-300 (1993); received November 11, 1992 Acetyl-CoA Carboxylase, Cycloxydim, Diclofop, Graminicides, Propionyl-CoA Carboxylase In higher plants the biosynthetic machinery of de novo fatty acid biosynthesis, measured as [14C]acetate incorporation into fatty acids, is predominantly located in plastids. A key enzyme in this pathway is the biotin-containing acetyl-CoA carboxylase (ACC, EC 6.4.1.2) which catalyzes the ATP-dependent carboxylation of acetyl-CoA to malonyl-CoA. The ACC from Poaceae is very efficiently blocked by two herbicide classes, the cyclohexane-l,3-diones (e.g. sethoxydim, cycloxydim) and the aryloxyphenoxy-propionic acids (e.g. diclofop, fluazifop). It is shown that within the Poaceae not only different species but also different varieties exist which exhibit an altered sensitivity and tolerance towards both herbicide classes, which points to a mutation of the target enzyme ACC. In purifying the ACC we extended our research to the possible presence of other biotin-containing plant enzymes. In protein preparations from maize, oat, barley, pea and lentil we were able to demonstrate the carboxylation of acetyl-CoA, propionyl-CoA and methylcrotonyl-CoA. The two herbicide classes not only block the ACC, but also the activity of the propionyl-CoA carboxylase (PCC), whereas the methylcrotonyl- CoA carboxylase (MCC), a distinct biotin-containing enzyme from mitochondria, is not affected.
    [Show full text]
  • GENE LIST ANTI-CORRELATED Systematic Common Description
    GENE LIST ANTI-CORRELATED Systematic Common Description 210348_at 4-Sep Septin 4 206155_at ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 221226_s_at ACCN4 Amiloride-sensitive cation channel 4, pituitary 207427_at ACR Acrosin 214957_at ACTL8 Actin-like 8 207422_at ADAM20 A disintegrin and metalloproteinase domain 20 216998_s_at ADAM5 synonym: tMDCII; Homo sapiens a disintegrin and metalloproteinase domain 5 (ADAM5) on chromosome 8. 216743_at ADCY6 Adenylate cyclase 6 206807_s_at ADD2 Adducin 2 (beta) 208544_at ADRA2B Adrenergic, alpha-2B-, receptor 38447_at ADRBK1 Adrenergic, beta, receptor kinase 1 219977_at AIPL1 211560_s_at ALAS2 Aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia) 211004_s_at ALDH3B1 Aldehyde dehydrogenase 3 family, member B1 204705_x_at ALDOB Aldolase B, fructose-bisphosphate 220365_at ALLC Allantoicase 204664_at ALPP Alkaline phosphatase, placental (Regan isozyme) 216377_x_at ALPPL2 Alkaline phosphatase, placental-like 2 221114_at AMBN Ameloblastin, enamel matrix protein 206892_at AMHR2 Anti-Mullerian hormone receptor, type II 217293_at ANGPT1 Angiopoietin 1 210952_at AP4S1 Adaptor-related protein complex 4, sigma 1 subunit 207158_at APOBEC1 Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 213611_at AQP5 Aquaporin 5 216219_at AQP6 Aquaporin 6, kidney specific 206784_at AQP8 Aquaporin 8 214490_at ARSF Arylsulfatase F 216204_at ARVCF Armadillo repeat gene deletes in velocardiofacial syndrome 214070_s_at ATP10B ATPase, Class V, type 10B 221240_s_at B3GNT4 UDP-GlcNAc:betaGal
    [Show full text]
  • Structural and Functional Studies of Pyruvate Carboxylase Regulation by Cyclic Di-AMP in Lactic Acid Bacteria
    Structural and functional studies of pyruvate PNAS PLUS carboxylase regulation by cyclic di-AMP in lactic acid bacteria Philip H. Choia, Thu Minh Ngoc Vub, Huong Thi Phamb, Joshua J. Woodwardc, Mark S. Turnerb,d, and Liang Tonga,1 aDepartment of Biological Sciences, Columbia University, New York, NY 10027; bSchool of Agriculture and Food Sciences, University of Queensland, Brisbane, QLD 4072, Australia; cDepartment of Microbiology, University of Washington, Seattle, WA 98195; and dQueensland Alliance for Agriculture and Food Innovation, University of Queensland, Brisbane, QLD 4072, Australia Edited by Ronald R. Breaker, Yale University, New Haven, CT, and approved July 18, 2017 (received for review March 22, 2017) Cyclic di-3′,5′-adenosine monophosphate (c-di-AMP) is a broadly con- human pathogen Listeria monocytogenes (LmPC) (6). Pyruvate served bacterial second messenger that has been implicated in a carboxylase (PC) is a biotin-dependent, single-chain, multidomain wide range of cellular processes. Our earlier studies showed that enzyme that forms a 500-kDa tetramer and is conserved among c-di-AMP regulates central metabolism in Listeria monocytogenes most organisms, from bacteria to humans (22, 23), while in a col- by inhibiting its pyruvate carboxylase (LmPC), a biotin-dependent lection of Gram-negative bacteria PC contains two subunits with the α β enzyme with biotin carboxylase (BC) and carboxyltransferase (CT) stoichiometry 2 4 (24). PC catalyzes the ATP-dependent carbox- activities. We report here structural, biochemical, and functional ylation of pyruvate to produce oxaloacetate. The biotin, covalently studies on the inhibition of Lactococcus lactis PC (LlPC) by c-di-AMP. linked to the biotin carboxyl carrier protein (BCCP) domain, is The compound is bound at the dimer interface of the CT domain, at a carboxylated in an ATP-dependent reaction in the biotin carbox- site equivalent to that in LmPC, although it has a distinct binding ylase (BC) domain (Fig.
    [Show full text]